|
2025-02-18 |
2025-02-18 |
PS
Planned sale
|
Boyle Scott N
Chief Business Officer
Officer
|
669
-0.6%
3.15
USD 2,107
|
669
-0.6%
|
3.15
|
USD 2,107
|
|
|
2025-02-18 |
2025-02-14 |
PS
Planned sale
|
Boyle Scott N
Chief Business Officer
Officer
|
490
-0.4%
3.15
USD 1,544
|
490
-0.4%
|
3.15
|
USD 1,544
|
|
|
2023-02-10 |
2023-02-08 |
B
Purchase
|
Koppikar Utpal
Non-Executive Director
|
5,667
+inf%
5.60
USD 31,735
|
5,667
+inf%
|
5.60
|
USD 31,735
|
|
|
2022-04-12 |
2022-04-12 |
B
Purchase
|
Hirsch Andrew
President & CEO
Executive Director
|
10,000
+inf%
8.40
USD 84,000
|
10,000
+inf%
|
8.40
|
USD 84,000
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Crystal Adam
Chief Medical Officer
Officer
|
1,054
-6.6%
32.66
USD 34,420
|
1,054
-6.6%
|
32.66
|
USD 34,420
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Crystal Adam
Chief Medical Officer
Officer
|
13,946
-46.5%
31.59
USD 440,547
|
13,946
-46.5%
|
31.59
|
USD 440,547
|
|
|
2021-12-17 |
2021-12-17 |
PS
Planned sale
|
Salter Malcolm
Non-Executive Director
|
755
-6.4%
30.25
USD 22,839
|
755
-6.4%
|
30.25
|
USD 22,839
|
|
|
2021-11-19 |
2021-11-19 |
PS
Planned sale
|
Salter Malcolm
Non-Executive Director
|
755
-6.1%
40.11
USD 30,283
|
755
-6.1%
|
40.11
|
USD 30,283
|
|
|
2021-10-15 |
2021-10-15 |
PS
Planned sale
|
Salter Malcolm
Non-Executive Director
|
755
-5.7%
44.94
USD 33,930
|
755
-5.7%
|
44.94
|
USD 33,930
|
|
|
2021-10-05 |
2021-10-01 |
PS
Planned sale
|
Crystal Adam
Chief Medical Officer
Officer
|
5,112
-100.0%
45.99
USD 235,119
|
5,112
-100.0%
|
45.99
|
USD 235,119
|
|
|
2021-10-05 |
2021-10-01 |
PS
Planned sale
|
Crystal Adam
Chief Medical Officer
Officer
|
8,176
-61.5%
45.32
USD 370,563
|
8,176
-61.5%
|
45.32
|
USD 370,563
|
|
|
2021-10-05 |
2021-10-01 |
PS
Planned sale
|
Crystal Adam
Chief Medical Officer
Officer
|
1,712
-11.4%
44.25
USD 75,756
|
1,712
-11.4%
|
44.25
|
USD 75,756
|
|
|
2021-09-29 |
2021-09-27 |
PS
Planned sale
|
Prokupets Elena
Non-Executive Director
|
1,311
-0.3%
50.04
USD 65,604
|
1,311
-0.3%
|
50.04
|
USD 65,604
|
|
|
2021-09-29 |
2021-09-27 |
PS
Planned sale
|
Prokupets Elena
Non-Executive Director
|
539
-1.7%
50.04
USD 26,969
|
539
-1.7%
|
50.04
|
USD 26,969
|
|
|
2021-09-14 |
2021-09-13 |
PS
Planned sale
|
Prokupets Elena
Non-Executive Director
|
3,330
-0.6%
50.07
USD 166,743
|
3,330
-0.6%
|
50.07
|
USD 166,743
|
|
|
2021-09-14 |
2021-09-13 |
PS
Planned sale
|
Prokupets Elena
Non-Executive Director
|
3,330
-3.8%
50.07
USD 166,730
|
3,330
-3.8%
|
50.07
|
USD 166,730
|
|
|
2021-09-14 |
2021-09-10 |
PS
Planned sale
|
Prokupets Elena
Non-Executive Director
|
1,320
-0.2%
50.01
USD 66,010
|
1,320
-0.2%
|
50.01
|
USD 66,010
|
|
|
2021-09-14 |
2021-09-10 |
PS
Planned sale
|
Prokupets Elena
Non-Executive Director
|
1,230
-1.4%
50.00
USD 61,501
|
1,230
-1.4%
|
50.00
|
USD 61,501
|
|
|
2021-09-14 |
2021-09-10 |
PS
Planned sale
|
Siegel Jolie
Chief Legal Officer
Officer
|
12,500
-100.0%
50.00
USD 625,000
|
12,500
-100.0%
|
50.00
|
USD 625,000
|
|
|
2021-08-02 |
2021-08-02 |
PS
Planned sale
|
Prokupets Elena
Non-Executive Director
|
4,257
-4.0%
45.01
USD 191,606
|
4,257
-4.0%
|
45.01
|
USD 191,606
|
|
